A detailed history of Meeder Asset Management Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 15,137 shares of KOD stock, worth $93,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,137
Previous 15,137 -0.0%
Holding current value
$93,698
Previous $35,000 11.43%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$2.29 - $4.48 $34,663 - $67,813
15,137 New
15,137 $35,000
Q3 2021

Nov 08, 2021

SELL
$81.97 - $106.94 $122,791 - $160,196
-1,498 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$77.2 - $126.54 $6,021 - $9,870
78 Added 5.49%
1,498 $139,000
Q1 2021

Apr 28, 2021

BUY
$110.45 - $164.47 $156,839 - $233,547
1,420 New
1,420 $161,000
Q4 2020

Feb 09, 2021

SELL
$60.78 - $154.03 $22,610 - $57,299
-372 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$45.05 - $59.27 $52,933 - $69,642
-1,175 Reduced 75.95%
372 $21,000
Q2 2020

Aug 11, 2020

BUY
$42.74 - $66.25 $19,874 - $30,806
465 Added 42.98%
1,547 $83,000
Q1 2020

May 15, 2020

SELL
$38.18 - $73.95 $687 - $1,331
-18 Reduced 1.64%
1,082 $52,000
Q4 2019

Feb 13, 2020

BUY
$13.9 - $76.65 $15,290 - $84,315
1,100 New
1,100 $79,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $322M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.